462 related articles for article (PubMed ID: 32534109)
1. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery.
Lazaridis C; Vlachogiannis NI; Bakogiannis C; Spyridopoulos I; Stamatelopoulos K; Kanakakis I; Vassilikos V; Stellos K
Hellenic J Cardiol; 2020; 61(6):381-395. PubMed ID: 32534109
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and cardiovascular system-a comprehensive review.
AlShahrani I; Hosmani J; Shankar VG; AlShahrani A; Togoo RA; Yassin SM; Khan S; Patil S
Rev Cardiovasc Med; 2021 Jun; 22(2):343-351. PubMed ID: 34258902
[TBL] [Abstract][Full Text] [Related]
3. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.
Ruzzenenti G; Maloberti A; Giani V; Biolcati M; Leidi F; Monticelli M; Grasso E; Cartella I; Palazzini M; Garatti L; Ughi N; Rossetti C; Epis OM; Giannattasio C;
High Blood Press Cardiovasc Prev; 2021 Sep; 28(5):439-445. PubMed ID: 34173942
[TBL] [Abstract][Full Text] [Related]
4. Covid-19 and the cardiovascular system: a comprehensive review.
Azevedo RB; Botelho BG; Hollanda JVG; Ferreira LVL; Junqueira de Andrade LZ; Oei SSML; Mello TS; Muxfeldt ES
J Hum Hypertens; 2021 Jan; 35(1):4-11. PubMed ID: 32719447
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and cardiovascular diseases.
Liu F; Liu F; Wang L
J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and management of myocardial injury in coronavirus disease 2019.
Wei ZY; Geng YJ; Huang J; Qian HY
Eur J Heart Fail; 2020 Nov; 22(11):1994-2006. PubMed ID: 32683753
[TBL] [Abstract][Full Text] [Related]
8. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.
Bienvenu LA; Noonan J; Wang X; Peter K
Cardiovasc Res; 2020 Dec; 116(14):2197-2206. PubMed ID: 33063089
[TBL] [Abstract][Full Text] [Related]
9. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes.
Kaye AD; Spence AL; Mayerle M; Sardana N; Clay CM; Eng MR; Luedi MM; Carroll Turpin MA; Urman RD; Cornett EM
Best Pract Res Clin Anaesthesiol; 2021 Oct; 35(3):437-448. PubMed ID: 34511231
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of cardiovascular manifestations of COVID-19: a narrative review.
Bilehjani E; Fakhari S; Farzin H; Tajlil A; Nader ND
Acta Cardiol; 2024 May; 79(3):267-273. PubMed ID: 37606350
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.
Zhao YH; Zhao L; Yang XC; Wang P
Rev Cardiovasc Med; 2021 Mar; 22(1):159-165. PubMed ID: 33792257
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular system and COVID-19: perspectives from a developing country.
Kunal S; Gupta K; Sharma SM; Pathak V; Mittal S; Tarke C
Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32380802
[TBL] [Abstract][Full Text] [Related]
14. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System.
Ernzen K; Trask AJ; Peeples ME; Garg V; Zhao MT
Stem Cell Rev Rep; 2021 Dec; 17(6):2107-2119. PubMed ID: 34365591
[TBL] [Abstract][Full Text] [Related]
15. Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot.
Chakafana G; Mutithu D; Hoevelmann J; Ntusi N; Sliwa K
Clin Res Cardiol; 2020 Dec; 109(12):1460-1468. PubMed ID: 32809116
[TBL] [Abstract][Full Text] [Related]
16. An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine.
Davoudi F; Miyashita S; Yoo TK; Lee PT; Foster GP
Crit Pathw Cardiol; 2022 Sep; 21(3):123-129. PubMed ID: 35994720
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.
Talasaz AH; Kakavand H; Van Tassell B; Aghakouchakzadeh M; Sadeghipour P; Dunn S; Geraiely B
Cardiovasc Drugs Ther; 2021 Apr; 35(2):249-259. PubMed ID: 32671601
[TBL] [Abstract][Full Text] [Related]
18. Management of acute cardiovascular events in patients with COVID-19.
Liao CT; Chang WT; Yu WL; Toh HS
Rev Cardiovasc Med; 2020 Dec; 21(4):577-581. PubMed ID: 33388002
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link?
Patil M; Singh S; Henderson J; Krishnamurthy P
J Cell Physiol; 2021 May; 236(5):3366-3382. PubMed ID: 33078408
[TBL] [Abstract][Full Text] [Related]
20. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry.
Gómez-Mesa JE; Galindo-Coral S; Montes MC; Alarco W; Barisani JL; Magaña A; Perna ER; Romero A; Speranza M; Mendoza I; Wyss F
Glob Heart; 2021 Feb; 16(1):14. PubMed ID: 33833938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
